Skip to content
10-Q

Quarterly Report

BioCorRx Inc. BICX

0001477932-24-004732

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 10.89M sh
Stockholders Equity Q2 2024 · Jun 30, 2024 −$11M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$9.82M
Current Liabilities Q2 2024 · Jun 30, 2024 $7.31M
Current Liabilities Q2 2024 · Dec 31, 2023 $6.43M
Total Liabilities Q2 2024 · Jun 30, 2024 $11.63M
Total Liabilities Q2 2024 · Dec 31, 2023 $10.34M
Current Assets Q2 2024 · Jun 30, 2024 $172.01K
Current Assets Q2 2024 · Dec 31, 2023 $187.12K
Total Assets Q2 2024 · Jun 30, 2024 $478.54K
Total Assets Q2 2024 · Dec 31, 2023 $388.89K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $0
Cost Of Revenue Q2 2024 · Jun 30, 2024 $1.67K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $10.38K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $19.05K
Net Income Q2 2024 · Mar 31, 2024 −$1.24M
Net Income Q2 2024 · Jun 30, 2023 −$923.55K
Net Income Q2 2024 · Jun 30, 2023 −$1.93M
Net Income Q2 2024 · Mar 31, 2023 −$1.01M
Shares Diluted Q2 2024 · Jun 30, 2023 1.97M sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$968.9K
Sga Expense Q2 2024 · Jun 30, 2023 $711.03K
Sga Expense Q2 2024 · Jun 30, 2023 $1.51M
Rd Expense Q2 2024 · Jun 30, 2023 $238.42K
Rd Expense Q2 2024 · Jun 30, 2023 $475.81K
Operating Income Q2 2024 · Jun 30, 2023 −$946.9K
Operating Income Q2 2024 · Jun 30, 2023 −$2M
Revenue Q2 2024 · Jun 30, 2023 $19.64K
Revenue Q2 2024 · Jun 30, 2023 $60.08K